EXE-346

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameEXE-346
Drug Alias NameEXE-346
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsSquamous Intraepithelial LesionsPouchitisSquamous Intraepithelial Lesions of the Cervix +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesExegi Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoExegi Pharma LLC
Inactive CompaniesN/A
Active IndicationsSquamous Intraepithelial LesionsPouchitisSquamous Intraepithelial Lesions of the Cervix +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A